About Cardiolyse
Cardiolyse is a cloud-based ECG and heart rate variability (HRV) analytics platform that delivers medical-grade cardiac monitoring and predictive analytics for cardiovascular health. The company provides real-time remote heart health monitoring through integration with digital ECG devices, serving cardiologists, general practitioners, healthcare providers, and elevated-risk patient populations. The platform employs clinically proven machine learning algorithms to analyze up to 400 vital ECG parameters, detecting all types of arrhythmias, atrial fibrillation, myocardial infarction, and ventricular hypertrophy. Its patent-pending Universal ECG and Personal Baseline Scores enable prediction of heart attacks and strokes up to two months before they occur. The system generates personalized reports on vital cardiac parameters to guide medication adjustments and lifestyle modifications, increasing access to preventive care. Cardiolyse offers three primary solutions: remote real-time heart health monitoring for elevated risk groups, diabetes cardiovascular comorbidities prevention with specific cardiac parameter monitoring, and fatigue risk management for critical safety job performers. The platform is CE-certified and has analyzed over 3.2 million ECG recordings and 2.6 million HRV analyses, reportedly preventing 146 critical heart events. Founded by healthcare and cardiology experts with decades of combined experience, Cardiolyse aims to reduce healthcare system costs by preventing dangerous heart events and hospital readmissions through early detection and intervention.
Mission & Story
Mission
To deliver a holistic approach to prevent heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms
Clinical Focus
Medical conditions and clinical areas addressed by Cardiolyse.
Who It Serves
Milestones & Awards
Recent Milestones
Crowdfunding campaign on Aescuvest.de (October 2021), successful pilot at Startup Creasphere EXPO 6 by Plug and Play (June 2021), selected for EIT Health Catapult 2021 semi-final (June 2021), chosen for Health&Biotech accelerator by Deloitte Italy (June 2021), selected for Startup Creasphere Batch 6 (March 2021)
Awards & Recognition
Selected for EIT Health Catapult 2021, chosen for Deloitte Italy Health&BioTech Accelerator (1 of 6 from 350+ applicants), selected for Startup Creasphere by Plug and Play
Key Partnerships
Social & Media
Latest Updates
Cardiolyse is chosen for the first edition of the Health&Biotech accelerator by Deloitte Italy
Microsoft for Startups $120K Azure Sponsorship Offer Received
Cardiolyse shows a successful pilot project at EXPO 6 Startup Creasphere by Plug and Play
Cardiolyse has been accepted to the OpenAPI Bootcamp
Cardiolyse is the WINNER of the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma
Company Details
- Headquarters
- Helsinki, Finland
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.